Pioneering Duchenne drug approved for use on NHS Scotland<\/a>\n<\/p>\n\n However, the SMC did not approve an endometrial cancer drug called dostarlimab (Jemperli), due to concerns around its cost-effectiveness.\n<\/p>\n
\n SMC chair, Professor Scott Muir said: \u201cThe committee is pleased to be able to accept these new medicines for use by NHS Scotland.\n<\/p>\n
\n \u201cOsimertinib offers the potential to delay the progression of disease in patients with certain types of advanced, non-small cell, lung cancer.\n<\/p>\n
\n \u201cPembrolizumab used together with chemoradiotherapy offers improved survival outcomes for patients with locally advanced cervical cancer.\n<\/p>\n
\n \u201cSotatercept offers a new treatment option for PAH that can help reduce the burden of symptoms.\n<\/p>\n
\n \u201cNemolizumab provides another treatment option for atopic dermatitis which may allow some patients to better manage their condition.\n<\/p>\n
\n \u201cThe committee was unable to accept dostarlimab for the treatment of this group of patients with endometrial cancer.\n<\/p>\n
\n \u201cThe company\u2019s evidence around the cost effectiveness of the treatment was not sufficient.\n<\/p>\n
\n \u201cWe would welcome a resubmission from the company addressing the issues we have raised.\u201d\n<\/p>\n
\n The SMC is the national source of advice on the clinical and cost-effectiveness of all new medicines for NHS Scotland, with the aim of ensuring people in Scotland have timely access to beneficial new medicines.\n<\/p>\n
\n Members of the SMC committee make their decisions based on a broad range of evidence in order to help health professionals deliver the best possible care within the resources available.<\/p>\n","protected":false},"excerpt":{"rendered":"The treatments given the nod include osimertinib, also known as Tagrisso, for treating adults with some instances of…\n","protected":false},"author":2,"featured_media":378810,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[134,527,111,139,69],"class_list":{"0":"post-378809","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-health","9":"tag-healthcare","10":"tag-new-zealand","11":"tag-newzealand","12":"tag-nz"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/378809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=378809"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/378809\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/378810"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=378809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=378809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=378809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}